Stockreport

RedHill's Opaganib Protects Against Radiation-Induced Lung Inflammation and Fibrosis - New Publication [Yahoo! Finance]

Redhill Biopharma Ltd. - American Depositary Shares  (RDHL) 
US:NASDAQ Investor Relations: ir.redhillbio.com/investor-relations
PDF Opaganib is the first selective sphingosine kinase-2 ( SPHK2) inhibitor investigational drug targeting sphingolipid metabolism for the treatment of radiation-induced in [Read more]